Clinical Trials in Changzhi, Shanxi

16 recruiting

Showing 113 of 13 trials

Recruiting

The Construction of a Predictive Model for Gastric Cancer Immunotherapy Response Based on Tumor-Infiltrating Lymphocytes (TILs) and Histone H3K4me3 in the Tumor Microenvironment

Gastric CancerImmunotherapy
Changzhi People's Hospital Affiliated to Changzhi Medical College170 enrolled1 locationNCT07069842
Recruiting
Not Applicable

Mobile Applet for Weight Management in Obese Heart Failure Patients

Heart FailureWeight LossOverweight and Obesity+1 more
Heart Health Research Center830 enrolled26 locationsNCT06455878
Recruiting
Not Applicable

OGT-assisted Overlap Esophagojejunostomy Versus Traditional Overlap Method

Gastric Cancer
Nanfang Hospital, Southern Medical University344 enrolled12 locationsNCT05450835
Recruiting
Phase 4

SHengXIaN-QuYu DEcoction in Heart Failure With Reduced and Mildly Reduced Ejection Fraction

Heart Failure
China-Japan Friendship Hospital336 enrolled26 locationsNCT05583773
Recruiting
Phase 3

Evaluation of the Efficacy and Safety of AL2846 Capsule Combined With TQB2450 Injection Compared to Docetaxel Injection in Advanced Non-small Cell Lung Cancer Patients Who Have Failed With Immunotherapy.

Non-small Cell Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.518 enrolled71 locationsNCT05922345
Recruiting

PrevaLence of Albuminuria in Patients With CARdiovascular Disease and Type 2 Diabetes Mellitus in China: a National Cross-sectional Study

Cardiovascular DiseaseType 2 Diabetes Mellitus
Beijing Anzhen Hospital3,000 enrolled27 locationsNCT06336239
Recruiting

A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China

Liver CancerPancreatic CancerGastric Cancer+8 more
Zhujiang Hospital12,000 enrolled50 locationsNCT05638269
Recruiting
Not Applicable

Goal-directed Enteral Nutritional Perioperative Management

Esophagus Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences400 enrolled17 locationsNCT06510543
Recruiting

A Real-world Study of Camrelizumab Alone or in Combination With Apatinib/Chemotherapy for Advanced Gastric Cancer

Gastric CancerRWSPD-1 Immunotherapy
Changzhi People's Hospital Affiliated to Changzhi Medical College504 enrolled1 locationNCT06485271
Recruiting
Phase 3

D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure

Non-small Cell Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.522 enrolled86 locationsNCT06300177
Recruiting
Phase 1Phase 2

A Clinical Trial on the Safety and Efficacy of TQB3909 Tablets in Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) .

Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.107 enrolled25 locationsNCT05959694
Recruiting
Phase 3

Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence.

Hepatocellular Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.480 enrolled67 locationsNCT05862337
Recruiting

China Diabetes Type 1 Study (CD1S) by China Alliance for Type 1 Diabetes

DiabetesType1diabetes
Second Xiangya Hospital of Central South University20,000 enrolled11 locationsNCT05498974